Mode
Text Size
Log in / Sign up

Exploratory Study Finds Inflammatory Indices Associated With Mortality in Severe Pneumonia ICU PatientsTwo Simple Blood Numbers Could Predict Pneumonia Survival

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret SIRI and NLR associations with mortality cautiously as exploratory findings requiring external validation.

This retrospective single-center exploratory study included 100 ICU patients with severe pneumonia. The setting was an intensive care unit with a follow-up duration of 28 days. The primary outcome was 28-day all-cause mortality. Higher odds of death were noted. All patients were monitored throughout the study period in the specific cohort.

Researchers evaluated systemic inflammatory indices (SII, SIRI, NLR, PLR, IBI) against a non-death group. Higher odds of death were observed. SIRI and NLR remained independently associated with mortality after full adjustment. SIRI showed an odds ratio of 2.16 with a 95% CI 1.08–4.33. NLR showed an odds ratio of 2.12 with a 95% CI 1.14–3.95. SII and IBI associations were attenuated, and PLR was not independently associated. The death group consisted of 37 patients, and the non-death group consisted of 63 patients.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in this study. Limitations include that findings are exploratory and require external validation. The evidence suggests that selected inflammation-based indices may provide additional prognostic information beyond conventional severity markers. Clinicians should interpret these associations cautiously given the observational nature and lack of causal proof. Certainty is noted as exploratory. Funding or conflicts were not reported.

For years, doctors relied on standard scores to guess the outcome. These scores help, but they are not perfect.

They often miss subtle signs of trouble. Families are left guessing during the most stressful moments.

Uncertainty is hard to handle. It makes decision-making difficult for everyone involved.

The surprising shift in care

For years, doctors relied on standard scores to guess the outcome. These scores help, but they are not perfect.

They often miss subtle signs of trouble. Families are left guessing during the most stressful moments.

But here is the twist. A new study suggests simple blood tests could do better.

Researchers looked at specific markers in the blood. These markers are part of the immune system.

How the body reacts

Think of your blood like a traffic system. White blood cells are the police.

When infection hits, they rush to the scene. They work to stop the damage.

Sometimes, the traffic gets too heavy. The system gets overwhelmed.

This study looked at how busy that traffic is. They measured the ratio of different cell types.

Researchers looked at 100 ICU patients over one year. They checked routine blood tests taken when patients arrived.

They tracked who survived and who did not. They wanted to find a pattern.

Two specific markers stood out above the rest. Higher levels meant a much higher chance of death within 28 days.

This does not mean you can test this at home.

The numbers were called SIRI and NLR. They are calculated from standard lab work.

Doctors already order these tests for other reasons. This research suggests they might mean more.

What experts are saying

Experts say this adds useful information to the mix. It helps paint a clearer picture of risk.

It is not a crystal ball. It is a tool to help guide care.

Doctors use many tools to make decisions. This adds another piece to the puzzle.

What this means for patients

Patients should not panic over these numbers. Doctors use many tools to make decisions.

This is not a reason to worry alone. It is a reason to ask questions.

Talk to your medical team about your specific situation. They know the full context.

The limitations

The study was small and done at one hospital. Results need to be checked in larger groups.

It was also a retrospective review. This means they looked back at past records.

Future studies must confirm these findings. Science requires proof before changing practice.

More trials will happen to confirm these findings. Approval takes time to ensure safety and accuracy.

If validated, these tests could become standard. They would help doctors act faster.

This could save lives by guiding treatment sooner. But patience is key for real change.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundSevere pneumonia remains a major cause of intensive care unit admission and death, and practical tools for early risk stratification remain limited. We evaluated several readily available systemic inflammatory indices and their association with 28-day all-cause mortality in patients with severe pneumonia.MethodsThis retrospective single-center study included 100 ICU patients with severe pneumonia treated between January 2022 and December 2023. The primary endpoint was 28-day all-cause mortality. Patients were classified into a death group (n = 37) and a non-death group (n = 63). Systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and inflammatory burden index (IBI) were calculated from routine laboratory data. Logistic regression models with progressive adjustment were used to evaluate the independent associations of these indices with 28-day mortality.ResultsSeveral inflammatory indices were higher in patients who died within 28 days. In unadjusted and minimally adjusted analyses, SIRI, NLR, and IBI were significantly associated with 28-day mortality. After further adjustment for age, sex, body mass index, smoking, drinking, admission APACHE II score, oxygenation index, mechanical ventilation duration, and major baseline comorbidities, only SIRI and NLR remained independently associated with 28-day mortality. In the fully adjusted model, each 1-standard deviation increase in SIRI and NLR was associated with higher odds of 28-day death (SIRI: OR 2.16, 95% CI 1.08–4.33; NLR: OR 2.12, 95% CI 1.14–3.95). By contrast, the associations of SII and IBI were attenuated after additional adjustment, and PLR was not independently associated with 28-day mortality.ConclusionAmong the evaluated inflammatory indices, SIRI and NLR showed the most stable independent associations with 28-day all-cause mortality in severe pneumonia. These findings are exploratory and require external validation, but they suggest that selected inflammation-based indices may provide additional prognostic information beyond conventional severity markers.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.